The FDA has approved Gazyva (obinutuzumab) for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.

Roche has received FDA approval for its antibody treatment Gazyva to be used in combination with standard therapy for adults with active lupus ...

The FDA has approved Genentech’s Gazyva (obinutuzumab) for the treatment of lupus nephritis in adults, according to a news release published today. Gazyva is the first and only anti-CD20 monoclonal ...

Simultaneous PD-1/VEGF/CTLA-4 blockade aims to compress multi-drug regimens into a single infusion, raising questions about ...

Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently completed a Phase 2 clinical study ...

Former NFL player Nate Collins joined Sam and Joe to give the Cleveland Browns some advice for the rest of the season: play the kids! Florida’s $83 million land deal is ‘an abomination"| Letters ‘All ...

At a live event in White Plains, New York, Adriana Rossi, MD, assistant professor of medicine and director of CAR T and the Stem Cell Transplant Clinical Service at the Center of Excellence for ...

Spirit Airlines has reached a series of proposed deals with its principal aircraft leasing firm that would deliver a cash infusion to the troubled budget carrier, according to filings in U.S.

Please provide your email address to receive an email when new articles are posted on . In this video, Joshua Brody, MD, discusses results from an ongoing phase 1a study of bexobrutideg, a novel ...

Infusion volumes at Baptist MD Anderson Cancer Center in Jacksonville, Fla., have more than doubled since 2019, surpassing 39,000 annual visits, without adding a single chair. This growth, which ...